TrialPhase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis
Trial details
- Registry ID
- NCT05796765
- Phase
- Phase 2
Drug research
Micronized DHACM 100 mg
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee OsteoarthritisNCT05796765 | MDXG | Phase 2 | Terminated | 2023-12-15Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |